The revenue of the in-vitro diagnostics market in 2017 was estimated at $63bn and was dominated by the Point of Care Testing Segment. The Molecular Diagnostics segment will be the fastest growing segment in the first-half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 263-page report you will receive 107 tables and 81 figures– all unavailable elsewhere.

The 263-page report provides clear detailed insight into the in-vitro diagnostics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Download Free Sample Pages of this report

Report Scope

This report breaks down the revenue forecast for the main submarkets by Type:

  • Point of care
  • Clinical chemistry
  • Immunochemistry
  • Haematology
  • Microbiology
  • Molecular Diagnostics
  • Flow Cytometry
  • Others

The Point of Care Diagnostic submarket is further segmented into:
  • Blood Glucose Testing
  • Infectious Disease Testing
  • Rapid Coagulation Testing
  • Cholesterol Testing
  • Pregnancy Testing

The Clinical Chemistry submarket is further segmented into:
  • Basic Metabolic Panel
  • Electrolyte Panel
  • Liver Profile
  • Lipid Profile
  • Thyroid Function Test

The Immunochemistry submarket is further segmented into:
  • ELISA
  • Immuno-PCR
  • Rapid Test
  • Western Blot
  • Enzyme linked Immunospot Assay

This report breaks down the revenue forecast for the main submarkets by Application:
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Autoimmune Diseases
  • Renal Diseases
  • Pharmacogenomics
  • HIV/AIDS
  • Other Applications

Download Free Sample Pages of this report

This report breaks down the revenue forecast for the main submarkets by Products & Services:
  • Analyzers
  • Reagents
  • Software & Services

This report breaks down the revenue forecast for the main submarkets by End-User:
  • Lab Testing
  • Hospital Testing
  • University Testing
  • Home Care Testing

This report provides individual revenue forecasts to 2028 for these regional and national markets:
  • Americas: US, Canada, Mexico, Brazil, Rest of Americas
  • Europe: UK, Germany, France, Spain, Italy, Russia, Rest of Europe
  • Asia: India, China, Japan, Rest of Asia
  • RoW

Each regional and national market is further segmented by type.

Our study includes SWOT analysis and STEP analysis of the in-vitro diagnostics market.

Our study discusses the selected leading companies that are the major players in the in-vitro diagnostics market:
  • Abbott Diagnostics
  • Agilent Technologies
  • Becton, Dickinson and Company (BD)
  • BioMerieux
  • Bio-Rad
  • Danaher Corporation
  • DiaSorin Diagnostics s.p.a
  • Roche Diagnostics
  • Siemens Diagnostics
  • Sysmex Corporation

Download Free Sample Pages of this report

This study is intended for anyone requiring commercial analyses for the in-vitro diagnostics market. You find data, trends and predictions.

Buy our report today In-Vitro Diagnostics World Market 2018-2028: Point of Care, Clinical Chemistry, Immunochemistry, Haematology, Microbiology, Molecular Diagnostics, Flow Cytometry, Infectious Diseases, Diabetes, Cardiology, Autoimmune Diseases, Renal Diseases, Pharmacogenomics, HIV/AIDS, Reagent & Kits, Instruments, Data Management Software & Services, Hospitals, Laboratories, Home Care Testing, Research Institutes, Blood Glucose Testing, Infectious Disease Testing, Rapid Coagulation Testing, Cholesterol Testing, Pregnancy Testing, Basic Metabolic Panel, Electrolyte Panel, Liver Profile, Lipid Profile, Thyroid Function Test, ELISA, Immuno-PCR, Rapid Test, Western Blot, Enzyme linked Immunospot Assay
 

Interested in a copy of this report?
Contact me for a personal quote:

Stefan Koopman
stefan.koopman@asdreports.com